Trial intelligence / Profile preview

Topical Vitamin D3 and Diclofenac for Basal Cell Carcinoma

NCT01358045Phase 2Completed

Sponsor
Maastricht University Medical Center+
Start
Nov 2011
Primary completion
Feb 2013
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of calcitriol, diclofenac in basal cell carcinoma (BCC), sponsored by Maastricht University Medical Center+. Started Nov 2011; status: completed.

02

Drugs

calcitrioldiclofenac
03

Conditions

basal cell carcinoma (BCC)

Beyond the preview

Go deeper on NCT01358045.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01358045.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call